Tiny Mirati Therapeutics Gets Jump On Giant Amgen In Cancer Drug

Tiny Mirati Therapeutics Gets Jump On Giant Amgen In Cancer Drug

Tiny Mirati Therapeutics posted positive preliminary data on a colorectal and lung cancer drug therapy in competition with drug giant Amgen, sending MRTX stock soaring to an all-time high.